LakeShore Biopharma Co., Ltd. (LSB)

Last Closing Price: 0.80 (2025-08-28)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

LakeShore Biopharma Co., Ltd. (LSB) had Net Income of $-13.93M for the most recently reported fiscal year, ending 2025-03-31.

Figures for fiscal year ending 2025-03-31
Income Statement Financials
$85.67M
Net Income
$-13.93M
$15.01M
$70.66M
$97.69M
$-12.02M
$-2.04M
$-14.06M
$-14.06M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-12.02M
$-6.92M
19.16M
19.16M
$-0.73
$-0.73
Balance Sheet Financials
$117.33M
$57.61M
$73.20M
$190.53M
$114.90M
$3.27M
$6.01M
$120.91M
$69.62M
$59.47M
$69.62M
20.77M
Cash Flow Statement Financials
$-16.85M
$-2.37M
$-0.50M
$34.35M
$14.97M
$-19.37M
$1.89M
--
--
Fundamental Metrics & Ratios
1.02
--
--
0.04
0.83
82.47%
-14.03%
-14.03%
-8.07%
-16.41%
-16.26%
$-18.51M
--
--
--
0.45
0.47
1.23
297.31
-20.01%
-23.42%
-7.31%
-19.11%
$3.35
$-0.97
$-0.88